Projects per year
Fingerprint Dive into the research topics where Molly Kulesz-Martin is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 3 Similar Profiles
Keratinocytes
Medicine & Life Sciences
Skin
Medicine & Life Sciences
Carcinogenesis
Medicine & Life Sciences
Neoplasms
Medicine & Life Sciences
Carcinogens
Medicine & Life Sciences
DNA
Medicine & Life Sciences
Squamous Cell Carcinoma
Medicine & Life Sciences
Proteins
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects 1981 2020
Illuminating molecular targetable pathways in HNSCC
Kulesz-Martin, M. & McWeeney, S.
8/1/15 → 7/31/20
Project: Research project
Atlases
Neoplasms
Genome
Pharmaceutical Preparations
Heterografts
Trim32 regulation of PKC-zeta in atopic dermatitis
Kulesz-Martin, M., Kulesz-Martin, M., Liu, Y. & Liu, Y.
Project: Research project
Microenvironmental impact on HNSCC response to targeted therapy
7/9/13 → 6/30/16
Project: Research project
Therapeutics
Neoplasms
Molecular Targeted Therapy
Cellular Microenvironment
Phosphatidylinositol 3-Kinases
Carcinogenesis
Cultured Cells
Epithelial Cells
Proteins
Neoplasms
Research Output 1980 2019
2
Citations
(Scopus)
Autophagy induction in atrophic muscle cells requires ULK1 activation by TRIM32 through unanchored K63-linked polyubiquitin chains
Di Rienzo, M., Antonioli, M., Fusco, C., Liu, Y., Mari, M., Orhon, I., Refolo, G., Germani, F., Corazzari, M., Romagnoli, A., Ciccosanti, F., Mandriani, B., Pellico, M. T., De La Torre, R., Ding, H., Dentice, M., Neri, M., Ferlini, A., Reggiori, F., Kulesz-Martin, M. & 3 others, , Jan 1 2019, In : Science Advances. 5, 5, eaau8857.Research output: Contribution to journal › Article
Open Access
muscle cells
muscles
induction
activation
mutations
Natural product target network reveals potential for cancer combination therapies
Chamberlin, S. R., Blucher, A., Wu, G., Shinto, L., Choonoo, G., Kulesz-Martin, M. & McWeeney, S., Jan 1 2019, In : Frontiers in Pharmacology. 10, MAY, 557.Research output: Contribution to journal › Article
Open Access
Biological Products
Neoplasms
Therapeutics
Drug Interactions
Pharmaceutical Preparations
8
Citations
(Scopus)
Complement C5a Fosters Squamous Carcinogenesis and Limits T Cell Response to Chemotherapy
Medler, T. R., Murugan, D., Horton, W., Kumar, S., Cotechini, T., Forsyth, A. M., Leyshock, P., Leitenberger, J. J., Kulesz-Martin, M., Margolin, A., Werb, Z. & Coussens, L., Oct 8 2018, In : Cancer Cell. 34, 4, p. 561-578.e6Research output: Contribution to journal › Article
Complement C5a
Carcinogenesis
Macrophages
T-Lymphocytes
Drug Therapy
1
Citation
(Scopus)
Induction of anaplastic lymphoma kinase (ALK) as a novel mechanism of EGFR inhibitor resistance in head and neck squamous cell carcinoma patient-derived models
Ouyang, X., Barling, A., Lesch, A., Tyner, J., Choonoo, G., Zheng, C., Jeng, S., West, T. M., Clayburgh, D., Courtneidge, S., McWeeney, S. & Kulesz-Martin, M., Oct 3 2018, In : Cancer Biology and Therapy. 19, 10, p. 921-933 13 p.Research output: Contribution to journal › Article
Epidermal Growth Factor Receptor
Small Interfering RNA
anaplastic lymphoma kinase
Carcinoma, squamous cell of head and neck
Neoplasms
Montagna Symposium 2017—Precision Dermatology: Next Generation Prevention, Diagnosis, and Treatment
Tolar, J., Bauer, J. W., Kaplan, D. H., Leachman, S., McGrath, J. A., Paller, A. S., Griffith-Bauer, K. A., Stemwedel, C. E. & Kulesz-Martin, M., Jun 1 2018, In : Journal of Investigative Dermatology. 138, 6, p. 1243-1248 6 p.Research output: Contribution to journal › Article
Precision Medicine
Dermatology
Genomics
Skin Diseases
Biomedical Research